Diphenhydramine


Thông tin thuốc gốc
Chỉ định và Liều dùng
Oral
Allergic conditions, Motion sickness
Adult: 25-50 mg 3 or 4 times daily. Max: 300 mg daily. For prevention of motion sickness, administer 30 minutes before exposure to motion.
Child: 2-6 years 6.25 mg 4-6 hourly; 6-12 years 12.5-25 mg 4-6 hourly; >12 years Same as adult dose. For prevention of motion sickness, administer 30 minutes before exposure to motion.

Oral
Short-term management of insomnia
Adult: 50 mg given 30 minutes before bedtime as needed.

Parenteral
Allergic conditions, Motion sickness
Adult: 10-50 mg up to 100 mg if needed via IV inj at a rate of 25 mg/min or deep IM inj. Max: 400 mg daily. For prevention of motion sickness, administer 30 minutes before exposure to motion.
Child: 5 mg/kg via IV inj at a rate of 25 mg/min or deep IM inj in 4 divided doses. Max: 300 mg daily. For prevention of motion sickness, administer 30 minutes before exposure to motion.

Parenteral
Parkinson's disease
Adult: 10-50 mg up to 100 mg if needed, via IV inj at a rate not exceeding 25 mg/min or via deep IM inj, when oral therapy is impossible or contraindicated. Max: 400 mg daily.

Topical/Cutaneous
Pruritic skin disorders
Adult: As 2% cream: Apply to affected area(s) up to max bid for not more than 3 days.
Child: ≥2 years Same as adult dose.
Cách dùng
May be taken with or without food.
Tương kỵ
IV/IM: Incompatible with amphotericin B, cefmetazole, cefalotin, hydrocortisone Na succinate, soluble barbiturates, contrast media, and strong acids or alkali solutions.
Chống chỉ định
Stenosing peptic ulcer or pyloroduodenal obstruction. Premature infants and neonates. Lactation. Concomitant use with other antihistamine-containing medicines (including topical antihistamines).
Thận trọng
Patient with narrow-angle glaucoma, prostatic hypertrophy or genitourinary obstruction, urinary retention, asthma, bronchitis, COPD, CV disease (e.g. hypertension, ischaemic heart disease), thyroid disorder, myasthenia gravis, seizure disorders (e.g. epilepsy). Moderate to severe renal and hepatic impairment. Elderly. Pregnancy.
Tác dụng không mong muốn
Significant: Drug tolerance (continuous use). Rarely, eczematous reactions (topical).
Blood and lymphatic system disorders: Haemolytic anaemia, thrombocytopenia, agranulocytosis.
Cardiac disorders: Palpitations, tachycardia, extrasystoles.
Gastrointestinal disorders: Dry mouth, epigastric distress, nausea, vomiting, diarrhoea, constipation.
General disorders and admin site conditions: Fatigue.
Metabolism and nutrition disorders: Anorexia.
Nervous system disorders: Sedation, drowsiness, restlessness, dizziness, excitability (children), headache.
Psychiatric disorders: Disturbance in attention, confusion, nervousness.
Renal and urinary disorders: Urinary frequency, urinary retention, difficulty in micturition.
Respiratory, thoracic and mediastinal disorders: Thickening of bronchial secretions.
Skin and subcutaneous tissue disorders: Sensitisation reaction, photosensitivity.
Vascular disorders: Hypotension.
IM/IV/Parenteral/PO: B
Thông tin tư vấn bệnh nhân
This drug may cause drowsiness or sedation, dizziness, blurred vision, cognitive and psychomotor impairment, if affected, do not drive or operate machinery.
Chỉ số theo dõi
Monitor mental alertness.
Quá liều
Symptoms: Drowsiness, sedation, mydriasis, fever, flushing, agitation, tremor, dystonic reactions, hallucination, ECG changes. Severe cases: Rhabdomyolysis, convulsions, delirium, toxic psychosis, arrhythmias, coma, cardiovascular collapse. May result in hallucinations, convulsions and death in paediatrics patients. Management: Supportive and symptomatic treatment. Administer parenteral diazepam for treatment of convulsions and marked CNS stimulation. May give vasopressors to treat hypotension.
Tương tác
May increase sedative effects of other CNS depressants (e.g. tranquilizers, hypnotics, anxiolytics). Enhanced and prolonged anticholinergic effects with MAOIs. May potentiate effects of anticholinergic agents (e.g. atropine, TCA). May diminish therapeutic effect of betahistine.
Potentially Fatal: Enhanced CNS depressant effects with other antihistamines (e.g. hydroxyzine).
Tương tác với thức ăn
May potentiate sedative effects of alcohol.
Ảnh hưởng đến kết quả xét nghiệm
May give false-positive result in urine detection of methadone and phencyclidine, serum TCA screening. May suppress wheal and flare reactions to skin test antigens.
Tác dụng
Description:
Mechanism of Action: Diphenhydramine, a monoethanolamine derivative, is an antihistamine with sedative and antimuscarinic properties. It competes with histamine for H1 receptor sites on effector cells in the blood vessels, gastrointestinal tract, and respiratory tract.
Duration: Histamine-induced wheal suppression: ≤10 hours; histamine-induced flare suppression: ≤12 hours.
Pharmacokinetics:
Absorption: Well absorbed from the gastrointestinal tract. Bioavailability: 42-62%. Time to peak plasma concentration: Approx: 1-4 hours.
Distribution: Widely distributed throughout the body including the CNS. Crosses the placenta, enters breastmilk. Volume of distribution: 17 L/kg. Plasma protein binding: 98.5%.
Metabolism: Extensively metabolised in the liver by CYP2D6 isoenzyme via N-demethylation and minor demethylation by CYP1A2, 2C9, 2C19; smaller degrees in pulmonary and renal systems; undergoes significant first-pass effect.
Excretion: Mainly via urine (as metabolites and unchanged drug). Elimination half-life: 2.4-9.3 hours.
Đặc tính

Chemical Structure Image

Source: National Center for Biotechnology Information. PubChem Database. Diphenhydramine, CID=3100, https://pubchem.ncbi.nlm.nih.gov/compound/Diphenhydramine (accessed on Jan. 21, 2020)

Bảo quản
Store below 25°C. Protect from light and moisture.
Phân loại MIMS
Thuốc kháng histamin & kháng dị ứng / Thuốc trị bệnh Parkinson / Thuốc trị chóng mặt / Thuốc ngủ & thuốc an thần
Phân loại ATC
R06AA02 - diphenhydramine ; Belongs to the class of aminoalkyl ethers used as systemic antihistamines.
D04AA32 - diphenhydramine ; Belongs to the class of topical antihistamines used in the treatment of pruritus.
Tài liệu tham khảo
Anon. Diphenhydramine (Systemic). Lexicomp Online. Hudson, Ohio. Wolters Kluwer Clinical Drug Information, Inc. https://online.lexi.com. Accessed 05/09/2019.

Anon. Diphenhydramine (Topical). Lexicomp Online. Hudson, Ohio. Wolters Kluwer Clinical Drug Information, Inc. https://online.lexi.com. Accessed 05/09/2019.

Buckingham R (ed). Diphenhydramine. Martindale: The Complete Drug Reference [online]. London. Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 05/09/2019.

Diphenhydramine Liquid (Major Pharmaceuticals). DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/. Accessed 05/09/2019.

Diphenhydramine Solution for Injection (Fresenius Kabi USA, LLC). DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/. Accessed 05/09/2019.

Diphenhydramine Tablet (Rugby Laboratories). DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/. Accessed 05/09/2019.

Histergan Cream (Norma Chemicals Ltd.). MHRA. https://products.mhra.gov.uk/. Accessed 05/09/2019.

Histergan/Paxidorm Tablets (Norma Chemicals Ltd.). MHRA. https://products.mhra.gov.uk/. Accessed 09/09/2019.

Thông báo miễn trừ trách nhiệm: Thông tin này được MIMS biên soạn một cách độc lập dựa trên thông tin của Diphenhydramine từ nhiều nguồn tài liệu tham khảo và được cung cấp chỉ cho mục đích tham khảo. Việc sử dụng điều trị và thông tin kê toa có thể khác nhau giữa các quốc gia. Vui lòng tham khảo thông tin sản phẩm trong MIMS để biết thông tin kê toa cụ thể đã qua phê duyệt ở quốc gia đó. Mặc dù đã rất nỗ lực để đảm bảo nội dung được chính xác nhưng MIMS sẽ không chịu trách nhiệm hoặc nghĩa vụ pháp lý cho bất kỳ yêu cầu bồi thường hay thiệt hại nào phát sinh do việc sử dụng hoặc sử dụng sai các thông tin ở đây, về nội dung thông tin hoặc về sự thiếu sót thông tin, hoặc về thông tin khác. © 2024 MIMS. Bản quyền thuộc về MIMS. Phát triển bởi MIMS.com
  • Dainakol
  • Dimedrol
  • Diphenhydramin Domesco
  • Donerkol
  • Dovergo
  • Enaulin
  • Nautamine
  • Neo-Allerfar
  • Nighlus
  • Noatanmine
  • SOSSleep
  • Tusstadt
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in